16-68230427-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_024939.3(ESRP2):c.2026G>A(p.Gly676Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00000137 in 1,460,854 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024939.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000799 AC: 2AN: 250228Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135176
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1460854Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 726622
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2026G>A (p.G676S) alteration is located in exon 14 (coding exon 14) of the ESRP2 gene. This alteration results from a G to A substitution at nucleotide position 2026, causing the glycine (G) at amino acid position 676 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at